TimeScale Financial’s Novo Nordisk NVO Stock Holding History

TimeScale Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$24.8K	Hold	306	–	–	0.01%	278
2023 Q1	$24.3K	Buy	306 +166	+119%	+$11.8K	0.01%	268
2022 Q4	$6.97K	Hold	140	–	–	﹤0.01%	346
2022 Q3	$7K	Hold	140	–	–	﹤0.01%	347
2022 Q2	$8K	Hold	140	–	–	﹤0.01%	317
2022 Q1	$8K	Hold	140	–	–	﹤0.01%	334
2021 Q4	$8K	Hold	140	–	–	﹤0.01%	333
2021 Q3	$7K	Hold	140	–	–	﹤0.01%	350
2021 Q2	$6K	Hold	140	–	–	﹤0.01%	365
2021 Q1	$5K	Hold	140	–	–	﹤0.01%	381
2020 Q4	$5K	Hold	140	–	–	﹤0.01%	338
2020 Q3	$5K	Buy	+140	New	+$4.67K	﹤0.01%	356

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TimeScale Financial's NVO Position: Q2 2023 in Review

TimeScale Financial held its Novo Nordisk (NVO) position steady in Q2 2023 at 306 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #278.

TimeScale Financial first reported a position in NVO in Q3 2020 and has held it in 12 quarters since. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

TimeScale Financial held 306 shares of Novo Nordisk worth $24.8K as of Q2 2023.
TimeScale Financial left its Novo Nordisk share count unchanged in Q2 2023.
Novo Nordisk made up 0.01% of TimeScale Financial's portfolio in Q2 2023, its #278 holding.
TimeScale Financial first reported a position in Novo Nordisk in Q3 2020 and has held it in 12 quarters since.
1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.